approval
Astrazeneca’s Calquence Combination Recommended for EU Approval in Untreated MCL Patients
2025-04-04
FDA Grants First-Ever Approval for MSC Therapy to Australian Company Mesoblast After Attempting for 4 Years
2024-12-20
GSK Expands Arexvy Approval to Adults Aged 50-59 at Increased Risk of Severe RSV Disease in Japan
2024-12-02
SoniVie Reports Major Advancements in Renal Denervation Program for Hypertension: REDUCED-1 Results, First-In-Human Data, FDA’s Crucial IDE Approval of Global THRIVE study
2024-07-24
LATEST
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan







